Farxiga CKD Trial Stopped Early For Efficacy, Giving The SGLT2 Inhibitor An Edge

 
• By Jessica Merrill
  
Business success concept with target as motivation (3D Rendering)
AstraZeneca's Farxiga was successful in chronic kidney disease • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Genitourinary

More from Therapeutic Category